Perkins Discovery Fund (PDFDX)

49.26
Net Asset Value
+0.39%
1 Day
+27.78%
Year-to-Date
Overall Morningstar Rating
Health
Style or Category
No Load
Sales Expenses
3.31%
Expense Ratio
Above Average
Morningstar Risk Rating™
Investment Objective The investment seeks long-term capital appreciation. The fund will invest- under normal circumstances- at least 80% of its net assets (plus any borrowings for investment purposes) in equity securities of domestic companies with market capitalizations of under $1 billion at the time of purchase. The equity securities the fund may purchase consist mostly of common stock- although the fund may purchase preferred and convertible stocks.

Performance

1 month+14.35% 3 years+11.75%
3 months+27.29% 5 years+9.89%
1 year+40.42% Since inception+10.29%
Data through --

Peer Comparisonvs. Health

 PDFDXCategory
Performance 5-yr return+9.89%+14.29%
Expense ratio3.31%1.29%
Risk 5 year sharpe ratio0.550.89
Net assets$7.5M$2.9B
Average market cap$668.0M$9.8B
Average P/E--22.0
Portfolio turnover18%18%

There are thousands of mutual funds to choose from. Get Money Magazine’s picks in all major categories.

Fund Management and Purchase Info

Fund familyPerkins
Fund manager & tenureRichard Perkins / 20 Years
Minimal initial investment$2,500.00
Minimum IRA investment$1,000.00

Holdings

U.S. stock96.07%
Cash3.20%
International stock0.73%
Fixed income0.00%
Other0.00%
Top 5 Sectors
Portfolio weighting
Healthcare 27.99%
Media 15.46%
Consumer service 10.21%
Energy 5.80%
Hardware 4.68%
Top 10 Holdings
Portfolio weighting
AXGN AxoGen Inc18.84%
PLUS ePlus inc10.31%
CSII Cardiovascular Systems Inc8.08%
BEAT BioTelemetry Inc6.87%
VCEL Vericel Corp6.60%
NEO Neogenomics Inc6.02%
SRCI SRC Energy Inc5.56%
ATRC AtriCure Inc5.29%
USAT USA Technologies Inc4.64%
RMTI Rockwell Medical Inc3.84%